SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-016124
Filing Date
2020-04-09
Accepted
2020-04-09 16:43:16
Documents
9
Period of Report
2020-04-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arav-8k_20200406.htm 8-K 62216
2 EX-10.1 arav-ex101_7.htm EX-10.1 92623
3 EX-10.3 arav-ex103_74.htm EX-10.3 92566
4 EX-10.4 arav-ex104_53.htm EX-10.4 151456
5 EX-10.5 arav-ex105_52.htm EX-10.5 190515
6 EX-10.6 arav-ex106_6.htm EX-10.6 91215
7 EX-10.7 arav-ex107_73.htm EX-10.7 29647
8 EX-99.1 arav-ex991_75.htm EX-99.1 22710
9 GRAPHIC g2mgclmznhfj000001.jpg GRAPHIC 6804
  Complete submission text file 0001564590-20-016124.txt   743942
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 20784965
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences